Clinicopathological features and prognostic significance of TAF1L in gastric cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High TAF1L expression correlates with poorer gastric cancer prognosis and is linked to specific tumor characteristics. This finding highlights TAF1L as a potential biomarker for predicting outcomes in gastric cancer patients.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- The role of TAF1L in gastric cancer (GC) development and progression remains unclear.
- Understanding TAF1L's correlation with clinicopathological factors and prognosis is crucial for GC management.
Purpose Of The Study
- To investigate the association between TAF1L expression and clinicopathological features in GC.
- To evaluate TAF1L as a prognostic biomarker for gastric cancer patients.
- To explore the potential role of TAF1L in GC treatment strategies.
Main Methods
- Immunohistochemistry was used to assess TAF1L expression in 120 GC patient samples.
- Correlation analysis was performed between TAF1L expression and clinicopathological characteristics.
- TCGA GC dataset was utilized for further bioinformatics analysis and validation.
Main Results
- Elevated TAF1L expression was observed in GC tissues and correlated with poor differentiation, signet-ring cells, dMMR status, lympho-vascular invasion, and neural invasion.
- High TAF1L expression was associated with significantly worse overall survival (OS), particularly in HER2-positive and pMMR subgroups.
- TAF1L and HER2 status were identified as independent prognostic factors in GC; TAF1L was a key risk factor in HER2-positive and pMMR patients.
Conclusions
- TAF1L expression is closely linked to the development and progression of gastric cancer.
- TAF1L serves as a significant biomarker for predicting GC prognosis.
- TAF1L may hold importance in guiding immunotherapy and targeted therapy for gastric cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...